EUVIMEDEUVIMED entdecken
Open Access

Uremic Clearance Granules Regulate Immune Equilibrium via Gut Microbiome to Alleviate Chronic Renal Failure

Qian Huang, Zhuowen Liang, Yuqing Cui, Jianxin Diao, Tianshu Zhou, Lei Shi, Zhixin Deng, Rushang Wang, Haitao Yuan, Kun Chen, Ying Du, Ali Chen und 2 weitere

Biomaterials Research · 01.01.2026 · 30

DOI: 10.34133/bmr.0342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials Research, online erschienen am 30.03.2026. Verfasst von Qian Huang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510006, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Basic and Applied Basic Research Fund-Natural Science Foundation of Guangdong.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic renal failure (CRF) is the common end point of various chronic kidney diseases, and there is currently no specific drug for CRF. Effectively halting its progression remains a clinical challenge. Gut microbiota disorders are a key factor influencing immune dysfunction in chronic kidney disease patients. Intervening in gut microbiota to improve immune regulatory function in patients could serve as a new strategy for treating CRF with Traditional Chinese Medicine. Uremic Clearance Granules (UCG), a Traditional Chinese Medicine formulation, effectively attenuate CRF progression, but their active components and mechanisms remain undefined. This study investigates how UCG mitigate CRF via coordinated regulation of gut microbiota, metabolites, and the T helper 17 cells / regulatory T cell axis. Using an adenine-induced CRF mouse model, we combined gut microbiota depletion, fecal microbiota transplantation, 16 S rRNA sequencing, and metabolomics to delineate the gut–kidney interactions underlying UCG efficacy. Flow cytometry quantified immune cell profiles in blood, and microbial intervention experiments verified the therapeutic role of Bifidobacterium animalis ( B. animalis ). In this study, we found that UCG treatment alleviated renal injury, reduced intestinal permeability, and up-regulated intestinal barrier markers. Microbiota depletion and fecal microbiota transplantation demonstrated that UCG’s renoprotective effects depend on gut microbial modulation. Specifically, UCG ameliorates CRF through gut–kidney axis remodeling by enhancing B. animalis abundance and sophocarpine, thereby rebalancing T helper 17/regulatory T immunity and preserving renal function. These findings identify a microbiota-dependent immunometabolic mechanism for UCG and highlight a potential therapeutic strategy for CRF via the drug–microbiota axis.

Autor:innen und Institutionen

  • Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510006, China.
  • School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong 510515, China.
  • Department of Faculty of Education, City University of Hong Kong, Hong Kong, China.
  • Consun Pharmaceutical Group Limited, Guangzhou, Guangdong 510006, China.
  • Center for Drug Research and Development, Guangdong Provincial Key Laboratory of Pharmaceutical Preparations Research and Evaluation, Guangdong Pharmaceutical University, Guangzhou 510006, China.

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Basic and Applied Basic Research Fund-Natural Science Foundation of Guangdong
  • Innovation Team Project - Scientific Research Project of Ordinary Universities in Guangdong Province

Zitieren

APA

Huang, Q., Liang, Z., Cui, Y., Diao, J., Zhou, T., Shi, L., Deng, Z., Wang, R., Yuan, H., Chen, K., Du, Y., Chen, A., Chen, J., & Xiao, W. (2026). Uremic Clearance Granules Regulate Immune Equilibrium via Gut Microbiome to Alleviate Chronic Renal Failure. Biomaterials Research, 30. https://doi.org/10.34133/bmr.0342

Vancouver

Huang Q, Liang Z, Cui Y, Diao J, Zhou T, Shi L, et al. Uremic Clearance Granules Regulate Immune Equilibrium via Gut Microbiome to Alleviate Chronic Renal Failure. Biomaterials Research. 2026;30. doi:10.34133/bmr.0342

BibTeX
@article{Huang2026,
  author = {Huang, Qian and Liang, Zhuowen and Cui, Yuqing and Diao, Jianxin and Zhou, Tianshu and Shi, Lei and Deng, Zhixin and Wang, Rushang and Yuan, Haitao and Chen, Kun and Du, Ying and Chen, Ali and Chen, Jiayun and Xiao, Wei},
  title = {Uremic Clearance Granules Regulate Immune Equilibrium via Gut Microbiome to Alleviate Chronic Renal Failure},
  journal = {Biomaterials Research},
  year = {2026},
  volume = {30},
  doi = {10.34133/bmr.0342}
}
Kostenlos starten →